| Ytd | 435.53% | |
| 1y | 567.58% |
| Open | 13.36 | Prev Close | 13.31 | Low | 13.29 | High | 14.94 | Mkt Cap | 6.62B |
| Vol | 16.99M | Avg Vol | 17.82M | EPS | -0.76 | P/E | N/A | Forward P/E | -68.16 |
| Beta | 0.76 | Short Ratio | 6.01 | Inst. Own | 70.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 8.96 | 200-d Avg | 4.95 | 1yr Est | 12.80 |
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Baird analyst Colleen Kusy maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Neutral and rai
Iovance Biotherapeutics (NASDAQ:IOVA) reported second-quarter financial results on Thursday. The tra
Corient Private Wealth LP purchased a new stake in Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) in t
Three healthcare stocks—Quantum-Si, Kodiak Sciences and Iovance—show overbought RSI readings above 8
Iovance raised 2026 revenue guidance to $410–$420 million as Amtagvi adoption accelerates, supported
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should tak
Leader in Global Drug Development of T Cell Therapies PHILADELPHIA, Oct. 01, 2026 (GLOBE NEWSWIRE) -
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Iovance hits a 52-week high after raising its 2026 revenue outlook to $410-$420 million on strong de
Wells Fargo analyst Yanan Zhu maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight a
Shares of Iovance Biotherapeutics are trading slightly lower Wednesday morning, taking a breather af
Iovance Biotherapeutics (IOVA) was a big mover last session on higher-than-average trading volume. T
FICO, IOVA, SDEV, CCL, MU were among the trending stocks on Tuesday, Sept. 29, 2026.
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) shares are trading higher on Tuesday as the company rais
Iovance Biotherapeutics upgrades 2026 revenue guidance to $410 million-$420 million. Key technicals,
Gainers Stablecoin Development (AMEX:SDEV) stock increased by 121.6% to $3.48 during Tuesday's
U.S. stocks fell as job openings declined; oil slid and gold rose. BKYI doubled, SSTI surged, while
Major indexes are moving lower as Treasury yields inch higher
HC Wainwright & Co. analyst Joseph Pantginis maintains Iovance Biotherapeutics (NASDAQ:IOVA)
U.S. stocks mixed as Dow fell 100+ points; CarMax surged 9.7% on strong results, while Iovance, Carn
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 26.8% to $0.32 during Tuesday's pre-mar
New Guidance Represents an Increase of $55 Million at the Midpoint from the Prior Range of $350 to $
Happily for investors, it flagged the biotech's shares as a buy. Goldman believes they have nearly 4
Goldman Sachs analyst Andrea Newkirk reinstates Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy
Iovance Biotherapeutics (NASDAQ: IOVA) said it is expanding its tumor-infiltrating lymphocyte, or TI
Iovance Biotherapeutics NASDAQ: IOVA said it is expanding its tumor-infiltrating lymphocyte, or TIL,
SAN CARLOS, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)
Biotech M&A surges in 2026, putting ABVX, IOVA, VKTX and BCRX on watchlists, as drugmakers seek late
Barclays analyst Etzer Darout maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight a
Squarepoint Ops LLC lessened its stake in Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) by 68.5% in t
Iovance Biotherapeutics (NASDAQ: IOVA - Get Free Report) and eXoZymes (NASDAQ: EXOZ - Get Free Repor
VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Iovance Biotherapeutics, Inc
Shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA - Get Free Report) reached a new 52-week high
Jupiter Topco LLC acquired a new stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) dur
SAN CARLOS, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA),
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
TD Cowen analyst Nicholas Lorusso maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and
Shares of Iovance Biotherapeutics are trending Friday morning after a momentum surge pushed the biot
Iovance Biotherapeutics stock hits a 52-week high as investors weigh Moderna-Merck cancer data, Amta
UBS analyst David Dai maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Neutral and raises t
Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX,
Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting str
Mizuho analyst Mara Goldstein maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Outperform a
Barclays analyst Etzer Darout maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight a
Citizens analyst Reni J. Benjamin maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Market O
Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares are surging Thursday after the cancer therapy compa
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday'
US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporti